Close

Production & Manufacturing

Aenova, SkyePharma in manufacturing alliance

Aenova France, a wholly-owned subsidiary Aenova Holding, will lease the whole pharmaceutical manufacturing business and the premises at Saint Quentin-Fallavier, Lyon to SkyePharma Group for an initial period of two years, extendable for a further three years. ...

TPI to start test runs at JCM manufacturing plant

China-based drug manufacturer Tianyin Pharmaceutical (TPI) is set to start test run at its 250-ton Jiangchuan Macrolide facility (JCM) for good manufacturing practice (GMP) certification process. The company will conduct the test runs by the end...

Spanish regulators give manufacturing license to Midatech Biogune

The Spanish Medicines Agency has given Investigational Medicinal Products (IMP) License to Midatech Biogune to manufacture clinical grade nanoparticles at its Bilbao manufacturing facility, Spain. Prior to licensing the manufacturing facility, the Spanish Medicines Agency has...

Unigene in contract manufacturing agreement with Cara

Unigene Laboratories, a provider of design, delivery, manufacture and development of peptide-based therapeutics, has entered into a clinical manufacturing agreement with Cara Therapeutics. Under the agreement, Unigene is expected utilize its peptide manufacturing technology to offer...

Pharmatek adds spray drying to drug manufacturing capabilities

Pharmatek Laboratories, a pharmaceutical chemistry development company, has added spray drying to its drug formulation and manufacturing capabilities.Pharmatek has acquired a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture. The technology...

APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced that it has entered into a commercialization, manufacture and supply agreement with Teva Pharmaceutical USA, Inc., a wholly owned subsidiary of Teva Pharmaceutical Industries Ltd.,...

Nycomed to acquire of majority stake in Guangdong Techpool Bio-Pharma

Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool), a fast-growing Chinese bio-pharmaceutical company based in Guangdong. Techpool, founded in 1993, specialises in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read